Diabetes Insipidus Diagnosis and Management

Pathophysiology and Clinical Consequences

• Patients with diabetes insipidus experience hypotonic polyuria, characterized by the excretion of large volumes of dilute urine with osmolality <200 mOsm/kg, according to Praxis Medical Insights 2, 3.
• The condition also leads to polydipsia, extreme thirst and craving for water, and a risk of hypernatremia and dehydration if fluid intake cannot match urinary losses, as noted by Praxis Medical Insights 2, 1.

Diagnostic Approaches

• Measuring ADH levels has limited diagnostic value in diabetes insipidus and is not recommended, with a class III evidence rating, as stated by Neurosurgery guidelines 4, 5.
• Plasma copeptin, a surrogate marker for ADH, is the preferred test, with levels >21.4 pmol/L indicating nephrogenic DI and levels <21.4 pmol/L suggesting central DI or primary polydipsia, according to Praxis Medical Insights 2, 3, 1.

Treatment Strategies

• For central DI, desmopressin, a synthetic ADH analog, is the treatment of choice, replacing the missing hormone, as confirmed by Praxis Medical Insights 2.
• For nephrogenic DI, treatment focuses on thiazide diuretics combined with dietary salt restriction, prostaglandin synthesis inhibitors, and a low-salt and low-protein diet, as recommended by Praxis Medical Insights 3, 1.